{
    "code": "02024472",
    "time": "2015-06-25 17:55:25",
    "許可證字號": "衛署藥輸字第024472號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/06\/30",
    "發證日期": "95\/06\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202447201",
    "中文品名": "必諾賓濃縮注射液",
    "英文品名": "Vinorelbine Injection Concentrate",
    "適應症": "非小細胞肺癌、移轉性乳癌。",
    "劑型": "270注射劑",
    "包裝": "1、5毫升小瓶 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "VINORELBINE TARTRATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路2段333號18樓",
    "主製造廠": {
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000610",
            "成分名稱": "VINORELBINE TARTRATE",
            "含量描述": "",
            "含量": "13.8500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 P02447201必諾賓注射劑Vinorelbine-final-103-01-07.pdf 020244720007.jpg 020244720006.jpg 020244720005.jpg 020244720004.jpg 020244720003.jpg 020244720002.jpg 020244720001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024472&Seq=008&Type=9"
        },
        {
            "title": "外盒 020244720011.jpg 020244720010.jpg 020244720009.jpg 020244720008.jpg 020244720007.jpg 020244720006.jpg 020244720005.jpg 020244720004.jpg 020244720003.jpg 020244720002.jpg 020244720001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024472&Seq=011&Type=8"
        }
    ]
}